ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,842.47
0.47%
US Tech 100
19,637.60
0.02%
Dow Jones
43,077.70
0.79%
Brent Oil
74.105
-0.49%
Bitcoin
67,752.41
1.11%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NKBP)

  7. China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NKBP) News

NKBP

China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NKBP)

China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NKBP
DateTimeSourceHeadlineSymbolCompany
07/25/20178:00AMBusiness WireNantKwest Announces Publication of Preclinical Data of haNK Cell Therapy in Combination with Checkpoint Inhibitor Avelumab Pr...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
02/07/20136:52AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
02/07/20136:24AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
02/07/20134:54AMGlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Completion of MergerNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
02/06/20135:14PMEdgar (US Regulatory)(25-NSE)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/29/20139:16AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/29/20139:14AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/29/20139:00AMGlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Reconvene Adjourned Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/18/20136:26AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/15/20139:03AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/15/20139:03AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/15/20137:28AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/15/20137:28AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/15/20134:00AMGlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Adjourns Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/14/20139:00AMGlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Proposes to Adjourn Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
12/17/20128:47AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
12/17/20128:47AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
12/17/20128:33AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
12/17/20128:33AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
12/14/20129:00AMGlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
11/27/20128:47AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
11/27/20128:47AMEdgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
11/27/20126:53AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
11/27/20126:53AMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
11/25/20129:00AMGlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
11/13/20124:35PMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
11/13/20124:35PMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
11/05/20128:00AMGlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Report Third Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
10/12/20125:00PMEdgar (US Regulatory)Statement of Ownership: Private Transaction (SC 13E3)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
10/06/201212:11PMBusiness WireRosen Law Firm Announces Investigation of China Nuokang Bio-Pharmaceutical In Connection With Going Private Proposal from Kin...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:NKBP

Your Recent History

NASDAQ
DRUG
Bright Minds Biosciences
USOTC
AXXA
Exxe (PK)
AMEX
BURU
Nuburu
USOTC
AFFU
Affluence (PK)
USOTC
RDGL
Vivos (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
CLNV
Clean Vision (QB)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
NLST
Netlist (QB)
USOTC
CYBL
Cyberlux (PK)
NASDAQ
AGBA
AGBA
USOTC
MONI
Moon Equity (PK)
USOTC
AAPJ
AAP (PK)
USOTC
HIRU
Hiru (PK)
USOTC
INKW
Greene Concepts (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved